Sasaki M, Sato M, Taguchi J, Ozaki M, Nose K, Hanada M, Akai F, Hayakawa T
Department of Neurosurgery, Toyonaka Municipal Hospital.
No Shinkei Geka. 1997 Feb;25(2):163-7.
A 51-year-old man presented with headache, vomiting and exophthalmus. Neurological examination revealed anosmia, papilledema, decrease in visual acuity, and disability in ocular movement. MRI showed a huge mass which occupied the whole nasal cavity and compressed the frontal lobe upwards and the eyes laterally. CT revealed an extensive bony destruction of the frontal base and bilateral orbits. The mass was biopsied transnasally, and was histologically diagnosed as olfactory neuroblastoma. It was highly radiosensitive and disappeared with a local irradiation of 40 Gy. Three months later the patient complained of a pain radiating from the neck to the right arm. MRI demonstrated a metastasis at the vertebral body of C5. Local irradiation of 30 Gy was performed. The metastatic lesion was removed, and a bone graft taken from the iliac bone was transplanted via an anterior cervical approach. Three weeks later, however, a hard mass appeared in the right of his neck and was surgically removed. By histological examination, it was also identified as a metastatic neuroblastoma to the cervical lymph node. A week after the removal of the cervical metastatic lesion, the metastasis extended rapidly to the left cervical and the bilateral hilar lymph nodes of the lungs. Chemotherapy was performed with a total doses of 800mg of cyclophosphamide, 1.5mg of vincristine, 40mg of pirarubicin, and 80mg of cisplatin. The lesions disappeared within 7 days. However, the patient died from disseminated intravascular coagulation 10 months after the onset. Olfactory neuroblastoma is usually an intranasal neoplasm, but it rarely extends intracranially and intraorbitally as is shown in our case. Basically, olfactory neuroblastoma is a relatively slow-growing tumor though it has a tendency to develop local recurrences over long periods even after aggressive primary treatment, and accompanied with distant metastases. However, our patient showed a very short survival time. Invasive extension and multiple metastases occurred during a short period, followed by disseminated intravascular coagulation. Combined chemotherapy at the initial treatment may be recommended in such an extensive case.
一名51岁男性患者出现头痛、呕吐和眼球突出症状。神经系统检查发现嗅觉丧失、视乳头水肿、视力下降以及眼球运动障碍。磁共振成像(MRI)显示一个巨大肿块占据整个鼻腔,并向上压迫额叶、向外侧压迫眼球。计算机断层扫描(CT)显示额底部和双侧眼眶广泛骨质破坏。经鼻对肿块进行活检,组织学诊断为嗅神经母细胞瘤。该肿瘤对放疗高度敏感,局部照射40 Gy后肿块消失。三个月后患者主诉颈部疼痛放射至右臂。MRI显示C5椎体转移。进行了30 Gy的局部照射。切除转移病灶,并通过颈前路取自髂骨的骨移植进行移植。然而,三周后患者颈部右侧出现一个硬结并手术切除。组织学检查也确定为颈部淋巴结转移性神经母细胞瘤。切除颈部转移病灶一周后,转移迅速扩展至左颈部和双侧肺门淋巴结。采用环磷酰胺800mg、长春新碱1.5mg、吡柔比星40mg和顺铂80mg的总剂量进行化疗。病灶在7天内消失。然而,患者在发病10个月后死于弥散性血管内凝血。嗅神经母细胞瘤通常是鼻内肿瘤,但像我们病例中这样很少向颅内和眶内扩展。基本上,嗅神经母细胞瘤是一种生长相对缓慢的肿瘤,尽管即使经过积极的初始治疗,它仍有长期局部复发的倾向,并伴有远处转移。然而,我们的患者生存时间非常短。在短时间内发生侵袭性扩展和多处转移,随后出现弥散性血管内凝血。对于如此广泛的病例,初始治疗时可能建议联合化疗。